| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0042 | 0.9 |